MTAP and familial pancreatic carcinoma: Glycolysis inhibitor 2-deoxy-d-glucose (2-DG) and purine synthesis inhibitor l-alanosine could synergistically exert anti-tumor effect on MTAP-deficient pancreatic cancer cells (Hu et al., 2021).